在肝细胞癌中治疗选择的范围
Hyun Phil Shin1, Moonhyung Lee1,2, Jung Won Jeon1
1Department of Internal Medicine, Kyung Hee University Hospital at Gangdong, Kyung Hee University College of Medicine, Seoul, Korea.
肝细胞癌 (HCC) 治疗正在发展,在早期阶段进行手术,移植和局部切除. 先进的全身疗法,包括免疫疗法,可以改善中等和高级HCC的存活率.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
背景情况:
- 肝细胞癌 (HCC) 是一个主要的全球健康问题,死亡率高.
- 现有的HCC治疗策略是多样化的,从手术干预到全身疗法.
研究的目的:
- 审查目前和新兴的肝细胞癌 (HCC) 治疗方法.
- 为突出外科手术,局部和全身疗法对HCC管理的进步.
主要方法:
- 关于HCC治疗选择的综合文献综述.
- 对手术切除,肝移植,局部切除,跨动脉疗法,放射治疗和全身治疗的分析.
- 评估免疫疗法和向疗法的最新进展.
主要成果:
- 手术切除是局部HCC与保存肝功能的主要治疗方法.
- 肝移植为肝功能受损的合格患者提供了很好的结果.
- 局部切除和跨动脉疗法为早期和中期HCC提供了有效的选择.
- 系统性治疗,包括向疗法和免疫检查点抑制剂,显著提高了生存率.
- 免疫疗法组合显示出作为HCC的第一线治疗方法的希望.
结论:
- 对HCC的治疗环境正在迅速发展,提供了更好的结果.
- 个性化治疗方法和新的治疗策略对于提高HCC管理中的患者存活率和生活质量至关重要.
更多相关视频
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
09:11Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
相关概念视频
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistant Cancers
Tumor Immunotherapy
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
